I was at a conference earlier this year and was wallowing in indecision as to what I wanted to do with the next step of my career/life. I had a job offer from another group and was trying to decide what to do.
This article was reviewed by Theo Seiler, MD, PhD
Reviewed by Raymond S. Douglas, MD, PhD, and Sara T. Wester, MD, FACS
This article was reviewed by Leslie Jones, MD
This article was reviewed by Allen C. Ho, MD, and M. Ali Khan, MD
Anti-vascular endothelial growth factor (VEGF) agents—including aflibercept, bevacizumab, and ranibizumab—have ushered in a new era in the treatment of retinal and choroidal neovascularization.
Originally believed to be primarily a disease of postmenopausal women with or without autoimmune disorders, it is now recognized that dry eye disease (DED) affects patients of both sexes at younger ages.
This article was reviewed by Friedrich E. Kruse, MD
Richard Adler, MD, shares the methods his practice has used to implement intense pulsed light (IPL) therapy into their patient base, while attending the 2019 American Academy of Ophthalmology's annual meeting in San Francisco.